Clinical Trial Update: Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating anlotinib in combination with chemoradiotherapy for locally advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Second Affiliated Hospital of Xi'an Jiaotong University | Conditions: Patients With Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN